Last reviewed · How we verify

Postop oral oxycodone & acetaminophen

AdventHealth · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Postop oral oxycodone & acetaminophen is a Small molecule drug developed by AdventHealth. It is currently FDA-approved. Also known as: Percocet.

Postop oral oxycodone and acetaminophen is used to treat pain, as well as conditions such as narcotic use, constipation, nausea, and shoulder pain. It works by acting as a mu opioid receptor agonist, a type of small molecule that binds to the mu-type opioid receptor.

At a glance

Generic namePostop oral oxycodone & acetaminophen
Also known asPercocet
SponsorAdventHealth
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Postop oral oxycodone & acetaminophen

What is Postop oral oxycodone & acetaminophen?

Postop oral oxycodone & acetaminophen is a Small molecule drug developed by AdventHealth.

Who makes Postop oral oxycodone & acetaminophen?

Postop oral oxycodone & acetaminophen is developed and marketed by AdventHealth (see full AdventHealth pipeline at /company/adventhealth).

Is Postop oral oxycodone & acetaminophen also known as anything else?

Postop oral oxycodone & acetaminophen is also known as Percocet.

What development phase is Postop oral oxycodone & acetaminophen in?

Postop oral oxycodone & acetaminophen is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing